Evidence map›Paper›PMID 33893233›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Ion mobility-mass spectrometry reveals the role of peripheral myelin protein dimers in peripheral neuropathy.

Sarah M Fantin, Kristine F Parson, Pramod Yadav, Brock Juliano, Geoffrey C Li, Charles R Sanders, Melanie D Ohi, Brandon T Ruotolo

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Charcot-Marie-Tooth disease type 1E: Clinical Natural History and Molecular Impact ofmedRxiv : the preprint server for health sciences · 2025
    Article
  5. Native Proteomics by Capillary Zone Electrophoresis-Mass Spectrometry.Angewandte Chemie (International ed. in English) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sarah M FantinDepartment of Chemistry, University of Michigan, Ann Arbor, MI 48109.ORCID 0000-0002-2509-1143
Kristine F ParsonDepartment of Chemistry, University of Michigan, Ann Arbor, MI 48109.ORCID 0000-0002-0194-6629
Pramod YadavLife Sciences Institute, University of Michigan, Ann Arbor, MI 48109.ORCID 0000-0003-0026-1684
Brock JulianoDepartment of Chemistry, University of Michigan, Ann Arbor, MI 48109.ORCID 0000-0001-6101-3890
Geoffrey C LiDepartment of Biochemistry, Vanderbilt University School of Medicine Basic Sciences, Nashville, TN 37240.ORCID 0000-0001-5035-5916
Charles R SandersDepartment of Biochemistry, Vanderbilt University School of Medicine Basic Sciences, Nashville, TN 37240.ORCID 0000-0003-2046-2862
Melanie D OhiLife Sciences Institute, University of Michigan, Ann Arbor, MI 48109.
Brandon T RuotoloDepartment of Chemistry, University of Michigan, Ann Arbor, MI 48109; bruotolo@umich.edu.ORCID 0000-0002-6084-2328
University of Michigan · USVanderbilt University · US

Funding

Folding, Misfolding, and Function of PMP22R01NS095989 · NINDS · VANDERBILT UNIVERSITY · PI Bruce D Carter, CHARLES R SANDERS · 2016 to 2026
$4.6M
New Structural Mass Spectrometry Tools Applied to the Mitochondrial Membrane ProtR01GM105942 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDREWS, PHILIP C, RUOTOLO, BRANDON T · 2013 to 2016
$1.4M
Orbitrap Fusion Lumos ETD with IRMPD for UM Chemistry MS Facility ExpansionS10OD021619 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAKANSSON, KRISTINA · 2016 to 2016
$1.1M
NIGMS NIH HHS R01 GM105942NIH HHS S10 OD021619NINDS NIH HHS R01 NS095989
6 · The paper itself

Abstract

Peripheral myelin protein (PMP22) is an integral membrane protein that traffics inefficiently even in wild-type (WT) form, with only 20% of the WT protein reaching its final plasma membrane destination in myelinating Schwann cells. Misfolding of PMP22 has been identified as a key factor in multiple peripheral neuropathies, including Charcot-Marie-Tooth disease and Dejerine-Sottas syndrome. While biophysical analyses of disease-associated PMP22 mutants show altered protein stabilities, leading to reduced surface trafficking and loss of PMP22 function, it remains unclear how destabilization of PMP22 mutations causes mistrafficking. Here, native ion mobility-mass spectrometry (IM-MS) is used to compare the gas phase stabilities and abundances for an array of mutant PM22 complexes. We find key differences in the PMP22 mutant stabilities and propensities to form homodimeric complexes. Of particular note, we observe that severely destabilized forms of PMP22 exhibit a higher propensity to dimerize than WT PMP22. Furthermore, we employ lipid raft-mimicking SCOR bicelles to study PMP22 mutants, and find that the differences in dimer abundances are amplified in this medium when compared to micelle-based data, with disease mutants exhibiting up to 4 times more dimer than WT when liberated from SCOR bicelles. We combine our findings with previous cellular data to propose that the formation of PMP22 dimers from destabilized monomers is a key element of PMP22 mistrafficking.

Indexed as

Cell MembraneHumansIon Mobility SpectrometryMass SpectrometryMembrane ProteinsMyelin ProteinsPeripheral Nervous System DiseasesProtein FoldingProtein StabilityProtein TransportSchwann CellsMembrane ProteinsMyelin ProteinsPMP22 protein, humanmass spectrometrymembrane proteinprotein misfolding

Identifiers

PMID33893233
PMCPMC8092585
OpenAlexW3152726940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.